| MOLECULAR AND CELLULAR ENDOCRINOLOGY | 卷:299 |
| Smoking and sVEGFR-1: Circulating maternal concentrations and placental expression | |
| Article | |
| Kaemaeraeinen, Meerit1  Soini, Tuuli1  Wathen, Katjoi-Anneli1  Leinonen, Elina1  Stenman, Ulf-Hakan2  Vuorela, Piia1  | |
| [1] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, Biomedicum, FIN-00290 Helsinki, Finland | |
| [2] Univ Helsinki, Cent Hosp, Dept Clin Chem, Biomedicum, FIN-00290 Helsinki, Finland | |
| 关键词: sVEGFR-1; sFIt-1; Pre-eclampsia; Smoking; Pregnancy; Placenta; | |
| DOI : 10.1016/j.mce.2008.11.028 | |
| 来源: Elsevier | |
PDF
|
|
【 摘 要 】
Smoking reduces the expression of VEGFR-1 in non-pregnant women. In pregnant women it reduces the risk of pre-eclampsia, which in turn is associated with increased placental expression of VEGFR-I and increased maternal circulating soluble VEGFR-I (sVEGFR-1). We therefore hypothesized that smoking might affect VEGFR-I expression in pregnant women. In maternal plasma sVEGFR-1 concentrations during the third trimester in both smoking (median 1088, range 834-1362 ng/L, n = 20) and non-smoking (728, 719-1336 ng/L, n = 19) women were higher than during the second trimester (smokers 374,291-683 ng/L, n = 6, p > 0.05; non-smokers 375, 290-667 ng/L, n = 22, p < 0.001). No difference was observed between smokers and non-smokers. Secretion of sVEGFR-1 into the culture medium, as well as the pattern and intensity of immunostaining in first trimester placenta were similar in tissue from smoking (n = 22) and non-smoking (n = 20) women. Thus, contrary to our hypothesis, smoking does not affect circulating maternal sVEGFR-1 concentrations or placental secretion of sVEGFR-1 or expression of VEGFR-I in vitro. (c) 2008 Elsevier Ireland Ltd. All rights reserved.
【 授权许可】
Free
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 10_1016_j_mce_2008_11_028.pdf | 478KB |
PDF